SÖNMEZ, M. Et Al. 2008. Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.33, no.3 , 329-330.

SÖNMEZ, M., çobanoğlu, Ü., OVALI, E., & OMAY, S. B., (2008). Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.33, no.3, 329-330.

SÖNMEZ, MEHMET Et Al. "Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.33, no.3, 329-330, 2008

SÖNMEZ, MEHMET Et Al. "Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.33, no.3, pp.329-330, 2008

SÖNMEZ, M. Et Al. (2008) . "Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.33, no.3, pp.329-330.

@article{article, author={MEHMET SÖNMEZ Et Al. }, title={Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure}, journal={JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS}, year=2008, pages={329-330} }